Patent · US Expired

Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia

US7510851B2 · kind B2 · utility

3Cited by
4References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2002
Grant dateMar 31, 2009
Priority date
Expiry dateMay 8, 2025

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/042
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia. In particular, the invention provides methods of identifying modulators of AKR1C as well as methods of diagnosing diabetes by measuring the levels of AKR1C or 9α, 11β-PGF2α in a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.